StockData
Compugen Ltd logo

Compugen Ltd (CGEN) stock

CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 2, 2026Score 12/30
$1.96−0.06 (-2.97%)

Close on Nov 18, 2026Market cap $185.32MP/E 5.2Yield –

Compugen operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was $31.33M. The highest annual figure on record is $31.33M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$31.33M–
FY2024Dec 31, 2024-$14.89M–
FY2023Dec 31, 2023-$12.99M–
FY2022Dec 31, 2022-$35.37M–
FY2021Dec 31, 2021-$35.07M–
FY2020Dec 31, 2020-$31.50M–
FY2019Dec 31, 2019-$28.88M–
FY2018Dec 31, 2018-$23.23M–
FY2017Dec 31, 2017-$37.41M–
FY2016Dec 31, 2016-$32.58M–
FY2015Dec 31, 2015-$20.92M–
FY2014Dec 31, 2014-$12.34M–
FY2013Dec 31, 2013-$17.04M–
FY2012Dec 31, 2012-$13.54M–
FY2011Dec 31, 2011-$11.98M–
FY2010Dec 31, 2010-$7.88M–
FY2009Dec 31, 2009-$7.63M–

More Compugen figures

See a number that looks wrong?